Custom Search


Genetics, Nutrition and Diabetes

Diabetes Mellitus is a metabolic problem of carbohydrate, lipid and protein.

 

We need to remember our 'real' history of body shape, food types and intake and activities of daily living. Our genes developed for hard work and lean food, but now foods with fat, salty and sweet tastes appeal and have overtaken the traditional roughage, carbohydrates, low energy dense foods and vegetables. Combined with our sedentary lifestyles, it is no wonder lifestyle diseases like obesity and diabetes are developing so quickly.

 

Risk factors for child onset Type 2 Diabetes

There are many risk factors, including obesity and increased body mass, family history, belonging to an ethnic minority, puberty (diagnosis commonly occurs here), female gender and any features of syndrome X metabolic syndrome. The common link between these risk factors is insulin resistance. Both insulin resistance and beta cell failure are present in diabetes.

 

What is diabetes?

Diabetes is an umbrella term to cover a group of metabolic disorders characterised by elevated blood glucose levels. It is usually a product of behaviour - for example overeating and leading a sedentary lifestyle. The onset of diabetes may also be due to new environmental pressures which unmask ex-survival genes, for example the genes that load fat stores become active. These may interact with various abnormal genes, environmental and endogenous toxins of pancreatic beta-cells and cause insulin resistance and lack of insulin secretion. This can lead to hyperglycaemia, dyslipidaemia and dysproteinaemia.

 

The classification of DMTI includes being insulin dependent, with autoimmune damage to pancreatic islet cells and strong heredity. For DMTII, it normally occurs in mid-older age, and is not insulin dependent. Maturity Onset Diabetes in the Young (MODY) is strongly genetic. Insulin resistance and secretion failure may or may not occur together in all diabetes.

 

The causes of DMTII are largely genetics, environmental factors, particulary our Western lifestyle of excess fat, highly refine foods and low fibre, inactivity, obesity and dietary toxins with low protective fruits and vegetables. When combined, these act on our survival genes resulting in obesity, and then with impaired fasting glucose or glucose intolerance, DMTII can develop.

 

 

Insulin Resistance

Genes, lifestyle and diet problems lead to insulin resistance. With normal beta-cell function in the pancreas, these problems would be compensated by hyperinsulinaemia to return to a state of normoglycaemia. The insulin output is increased to compensate for insulin resistance in the tissue - generally liver, skeletal muscle, adipose tissue - and the glucose tolerance remains within the normal range.

 

However, with abnormal beta-cell function, a relative state of insulin deficiency occurs because the amount of insulin secretion is insufficient to compensate for insulin resistance, which leads to hyperglycaemia and DMTII.

 

Progression to Diabetes

The initiating factors for diabetes are all genetic abnormalities in the following genes: insulin resistance genes, insulin secretion genes, beta-cell capacity genes and obesity genes.

 

The progression factors include obesity, beta-cell toxins, diet and environmental toxins, activity level and age.

 

The simplified process is:

  • Decreased insulin and glucose sensitivity
  • Increased insulin secretion
  • Glucose desensitisation of beta-cells
  • Failing insulin secretion
  • DMTII

 

Insulin is important as it helps glucose disposal into cells, inhibits hepatic gluconeogenesis and inhibits free fatty acid release from fat cells.

 

Insulin secretion problems are mainly found with DMTI. The opposite is found with DMTII - excess insulin is secreted as the end skeletal muscle, organ or tissue fails to sense insulin or act on the signal - so more is sent out to help uptake the circulating glucose. Eventually this wears out the pancreatic beta-cells which have been producing and secreting the insulin, and they fail. In non-diabetics this on its own is not normally enough to trigger DM.

 

Endothelial cells may become insulin resistant because of low blood flow and hypertension. The liver may also develop insulin resistance as there is persistent hepatic glucose production despite hyperglycaemia, and this causes the liver to release free fatty acids. The liver and fat cells trigger insulin resistance in the abdominally obese, and combined with metabolic syndrome results in further hyperglycaemia and dyslipidaemia.

 

 

Mechanisms of Insulin Resistance

There may be intracellular accumulation of acyl CoA and triglycerides. There may be a role of secretion from the adipose tissue to increase peptides which may combine with free fatty acids and triglycerides to trigger insulin resistance at the cells and low glucose transport. It is possible there may be a change in the insulin signalling cascade, or an increase in acyl CoA may alter gene expression.

 

Insulin signalling is heavily affected by genetic background. It affects the insulin secretion by the beta-cells, and insulin signalling in the central nervous system is responsible for regulation of energy disposal, fuel metabolism and reproduction.

 

Insulin resistance occurs frequently in the muscle. If lean and healthy, fat oxidation is inhibited by insulin. In obesity and DMTII, skeletal muscle is metabolically inflexible to allow transitions between fasting and insulin-stimulated fatty acid and glucose utilisation. This means that in obesity and DMTII, there is increased low-density lean tissue - fat laden skeletal muscle.

 

Fat excess kills cells - if there is an influx of fatty acids that exceeds their oxidative requirements, the unoxidised surplus enters the pathways of non-oxidative metabolism and triglyceride content rises. Non-oxidative products may cause dysfunction and death of cells.

 

Leptin may protect non-adipocyte cells from fat overload - this is a peptide secreted by fat and low levels increase hunger. It also affects reproduction.

 

Hyperglycaemia

The toxicity of hyperglycaemia is important in diabetes. The retina, kidney, nerves and capillaries fail from glucose damage. Glycated products cause oxidative stress and protein changes.

 

The Glycaemic Index is useful to categorise foods into groups that cause high or low glucose spikes once eaten. Hyperglycaemia is more likely after carbohydrate loads - highly cooked and refined foods are the worst. Protein and fats eaten with carbohydrates reduce the GI of the food, but you have to be sensible about the type of fats used. There is much controversy over whether the GI is useful and valid, and whether energy density is more important. Generally high fruit and vegetables and low processed carbohydrates or traditional foods have a low GI.

Gene Hypothesis

The high prevalence of obesity and NIDDM in certain population groups suggests it may result from a 'thrifty genotype' - and that it is a real metabolic disease, not just as a result of gluttony. In DMTII, prediabetic phenotypes may be inherited for insulin secretion, insulin action and regulation of insulin signalling; and genome-wide scans of related families is possible to pinpoint the genetic differences to healthy people. At least 7 genetic defects are known.

 

Many biochemical systems are affected by DMTI, including peptide hormones, steroid hormones, vitamins and co-factors, trace elements, coagulation markers and energy management.

 

With DMTII, there are macrovascular changes, including causing insulin resistance or hyperinsulinaemia, hypertension and hormone changes, atherosclerosis, coronary heart disease, limb circulation problems leading to gangrene. Most diabetics die from myocardial infarction or cerebrovascular accident.

 

Microvascular damage includes hyperglycaemia due to insulin resistance and secretion reduction, retina problems leading to blindness, kidney failure, brain problems, and nerve problems resulting in skin ulcers, bowel dysfunction and gangrene.

 

System alterations of DMTII include steroid hormones and peptides, blood vessel lining damage which can lead to arteriosclerosis and deep vein thrombosis, immune depression leading to infections and chronic inflammation (this is a strong marker for CVD), and the disease is worse in women.

 

Health risks involved with metabolic syndrome include high cholesterol, blood pressure, gout, homocysteine, increased likelihood of developing DMTII, heart disease, stroke polycystic ovarian syndrome, where insulin resistance at the ovary interferes with vitamin d.

 

The definition of metabolic syndrome requires three of the following: waist circumference of at least 102cm in men or 88cm in women, serum triglycerides at least 150mg/dL, low HDL, high blood pressure and high serum glucose.

 

 

Oxidants

The increased free radical production under hyperglycaemic conditions may originate from mitochondrial respiration. Excess free radicals cause oxidative stress, leading to tissue dysfunction and damage. Glucose autoxidation depletes antioxidant stores, and this is made worse by hyperglycaemia causing glycated proteins and glycation of protective albumin. This leads to depletion or glycation of HDL and excess production of superoxide which triggers further free radical production. Advanced Glycosylation Endproducts (AGE) are also food derived and these are triggers for diabetes. It is important to be eating antioxidant rich foods and use appropriate antioxidant supplements such as carotenoids, a-tocopherol, vitamin c, folate, b6 and b12 to protect against oxidative damage.

 

Alpha-tocopherol prevents AGE forming in LDL.

 

Vitamin C prevents damage from glucose autoxidation and glycation of proteins, and protects the beta-cells in the pancreas.

 

Copper levels are highest in diabetics with microvascular problems. This would explain their higher zinc excretion levels and lower plasma zinc. They also have low magnesium and increased urinary levels of magnesium.

 

PPAR's - Peroxisome Proliferator Activated Receptors

These are a subfamily of the nuclear receptor family, and are ligand dependent (fatty acids and their derivatives). They play a central role in sensing nutrient levels and modulating their metabolism, energy metabolism and cell proliferation. They may also affect inflammation and blood vessel formation.

 

There are numerous links between PPAR's and obesity. Synthetic agonists for PPAR's are used to lessen abnormalities in lipid and glucose metabolism. Many abnormalities occur in parallel with obesity including dyslipidemia, insulin resistance, DMTII and hypercholesterolemia.

Diabesity or Diobesity?

Which order does the disease manifest? 80-90% of DMTII are overweight or obese. 75% of DMTII is attributable to obesity. Weight gain precedes this - diabetes reflects the effect of obesity. Insulin levels are raised in overweight people, and waist circumference is proportional to insulin levels. A regression of diabetes can be achieved with weight loss. Metabolic syndrome leads to impaired glucose tolerance which leads to diabetes. Visceral adiposity (fat storage) is most strongly related to skeletal muscle insulin resistance. Fat loss and physical activity will remedy this problem and reduce metabolic inflexibility.

 

Polycystic Ovarian Syndrome

Obesity, PCOS and later diabetes often co-exist. It produces high androgens in women. PCOS and obesity are insulin resistant states and often present in teenagers. The endocrine manifestation triggers infertility, menstrual disturbances and excess hair growth.

 

Diabetes and Pregnancy

Stress in the inutero environment causes the development of a phenotype known as the 'thrifty gene'. This is to aid the development of the fetus that has been set up to start off badly in life as a result of whatever the inuterine stress was (eg poor nutrition). These babies are more likely to develop obesity and diabetes as a result of their metabolism adjusting accordingly to store all incoming fuel instead of burning it. Small babies are more likely to become insulin resistant and hypertensive later in life and are at risk of CVD. Possible causes for this include adrenocorticoid effects, less elastic in the arteries, low growth hormone, genomic imprinting and non-permanent DNA modifications.

 

Gestational diabetes is closely related to DMTII, and the combination of insulin resistance and impaired insulin secretion is important in its pathogenesis. High birth weight is associated with obesity, and it is probable that the fetal exposure to the mother's diabetes gives a risk for diabetes above any genetically transmitted susceptibility.

 

Summary

The benefits of a 10% weight loss include significantly reducing mortality, diabetes, blood pressure, lipid and angina, and increasing HDL.

 

Diabetes Type 2 is a problem growing with obesity causing huge morbidity, mortality and economic burdens. It is spreading to most areas of the world. Insulin resistant genes have been caused by an interplay of environmental, obesity and unmasking survival genes factors. Once insulin resistance occurs, multiple systems and organ changes or failures vastly increase the risk of CVD and other diseases. The failure of systems such as oxidative stress management, coagulation, cytokines and inflammation activation, and multiple hormonal systems are damaged or disrupted. Macro and micronutrients are dealt with abnormally, and if we alter our convenience lifestyle and return to a more traditional wholefood diet and lifestyle, the problem would reduce. Nutrient, genetic and drug treatment is required to manage the micro and macrovascular diseases of DMTII.

 

Summarised from Anne-Thea McGill lecture, University of Auckland Medical School , October 2003

 
 



If you have any questions, enquires or would like to place a credit card order, please use our secure page to PAY NOW by Visa or Mastercard.

Alternatively, you can email me at belinda@absolutehealth.co.nz.



 

Check out our latest eBay specials! All prices are in US$


Sell more with every listing. Get Vendio Gallery today!